Srinivas Iyengar
Overview
Explore the profile of Srinivas Iyengar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OHair D, Iyengar S, Ware M
JACC Case Rep
. 2024 Dec;
29(21):102664.
PMID: 39619027
The transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve has shown better hemodynamic outcomes and better valve durability at 5 years when compared with a surgical aortic valve...
2.
Wickramasinghe N, Sachs D, Shewale B, Gonzalez D, Dhanan-Krishnan P, Torre D, et al.
Cell Stem Cell
. 2022 Mar;
29(4):559-576.e7.
PMID: 35325615
Pluripotent stem-cell-derived cardiomyocytes (PSC-CMs) provide an unprecedented opportunity to study human heart development and disease, but they are functionally and structurally immature. Here, we induce efficient human PSC-CM (hPSC-CM) maturation...
3.
Madhavan S, Reddy S, Panuganti P, Joshi R, Mallidi J, Raju K, et al.
Indian Pacing Electrophysiol J
. 2011 Jul;
11(4):93-102.
PMID: 21760680
Background: Sudden cardiac death (SCD) is a common initial presentation of coronary artery disease (CAD). Despite the growing epidemic of CAD in India, the epidemiology of SCD is largely unknown....
4.
Lei S, Iyengar S, Shan L, Cherwek D, Murthy S, Wong A
Clin Dysmorphol
. 2009 Dec;
19(2):79-81.
PMID: 20032780
No abstract available.
5.
Kirtane A, Gupta A, Iyengar S, Moses J, Leon M, Applegate R, et al.
Circulation
. 2009 Jun;
119(25):3198-206.
PMID: 19528338
Background: The safety and efficacy of drug-eluting stents (DES) among more generalized "real-world" patients than those enrolled in pivotal randomized controlled trials (RCTs) are controversial. We sought to perform a...
6.
Rabbani L, Iyengar S, Dangas G, Grines C, Cox D, Garcia E, et al.
J Interv Cardiol
. 2009 Jun;
22(4):378-84.
PMID: 19496901
The impact of thienopyridine administration prior to primary stenting in acute myocardial infarction (AMI) has not been well studied. We therefore examined the database from the prospective, multicenter, controlled CADILLAC...
7.
Iyengar S, Rabbani L
Am J Ther
. 2009 May;
17(5):516-22.
PMID: 19451810
The treatment paradigm for patients with an ST-elevation myocardial infarction (STEMI) has shifted greatly in the last 20 years. The use of fibrinolytic agents vastly altered the landscape in treating...
8.
Iyengar S, Meyers P, Goyal N, Moses J, Gray W
J Invasive Cardiol
. 2009 Feb;
21(2):60-4.
PMID: 19182292
Transcatheter percutaneous therapy for the treatment of vascular disease has markedly expanded over the last 20 years. This growth of endovascular technology has encouraged application of these modalities to vascular...
9.
Iyengar S, Gray W
Catheter Cardiovasc Interv
. 2009 Jan;
73(6):739-44.
PMID: 19133683
The use of a magnetic navigation system (MNS) to facilitate catheter placement in electrophysiologic procedures has been increasingly documented over the past decade. Recently, the utilization of MNS to aid...
10.
Iyengar S, Rabbani L
J Thromb Thrombolysis
. 2008 Apr;
27(3):300-6.
PMID: 18398577
The adenosine diphosphate (ADP) receptor antagonists, specifically the class of thienopyridines, have emerged as potent tools in the clinician's arsenal for the treatment of athero-thrombotic disease over the last two...